Buy Target – $4.32 or better Sell Target – TradersPro Sell Signal NIO Limited designs, manufactures, and sells electric vehicles in the People’s Republic of China, Hong Kong, the United States, the United Kingdom, and Germany. The company offers five, six, and seven-seater electric SUVs. It is also involved in the provision of energy and […]
Read MorePlus, Trump said Iran was responsible for an attack on the U.S. embassy in Iraq and said that he plans to sign the “phase one” trade deal with China on January 15.
Read MoreOne of the hallmarks of the market’s upward trend this year has been the strength of the U.S. economy, even in the face of trade uncertainty that seemed to abate only after the U.S. and China both confirmed an initial, in-principle “phase one” agreement that held off increased tariffs earlier this month, with negotiations ongoing […]
Read MorePlus, Tesla began delivering Model 3s from its new Shanghai factory, and AstraZeneca and Merck’s cancer drug just got approved to treat pancreatic cancer.
Read MoreBuy Target – $45.75 Sell Target – TradersPro Sell Signal Zymeworks Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The company’s lead product candidates include ZW25, a bispecific antibody that is in Phase I clinical trial for the treatment of breast and […]
Read MoreDigging through the thousands of publicly traded companies on U.S. stock exchanges, looking for value is something that can get tougher the longer a bull market lasts. That’s especially true for sectors and industries that have been leading the broad market’s trend. The Financial sector is a good example; as measured by the S&P 500 […]
Read MoreBuy Target – $14.50 or better Sell Target – TradersPro Sell Signal Aravive, Inc., a clinical stage biotechnology company, focuses on developing therapies for solid tumors and hematologic malignancies. Its lead candidate is AVB-S6-500, a soluble Fc-fusion protein, which is in Phase 1b/2 clinical trials for the treatment of platinum- resistant recurrent ovarian cancer, as […]
Read MorePlus, the stocks that led the market this decade and the ones analysts are bullish on for the year ahead.
Read MoreOne of the things I love about being an investor is the opportunity to talk to other investors. It’s certainly fun to share my own ideas about successful investing and my view of current economic conditions and events, but more importantly, I really like being able to compare notes, hear their ideas, and see how […]
Read MoreBank of America is bullish on these 4 stocks heading into the new year. Here’s why.
Read MoreNetflix may have won the 2010s, but these 5 stocks could be big winners in the new decade.
Read MoreGold prices have been quietly climbing higher, and one Wall Street veteran says investors should keep an eye on the shiny metal in the new year.
Read MoreThe firm says one basket of stocks could triple the market’s return next year. Here are 6 stocks that made the list.
Read MoreTrade Setup Buy Target $32.53 Sell Target $34.32 Crestwood Equity Partners LP provides infrastructure solutions to liquids-rich natural gas and crude oil shale plays in the United States. It operates through three segments: Gathering and Processing (G&P); Storage and Transportation (S&T); and Marketing, Supply and Logistics (MS&L). The G&P segment offers gathering and transportation services […]
Read MorePlus, initial jobless claims fell last week, shoppers broke records this holiday season, and Wedbush said Tesla is on an “upward trajectory.”
Read More